Clindamycin Hydrochloride
NDC 73614-204, Clindamycin Hydrochloride, capsule, from Brisk Pharmaceuticals.
- Product NDC
- 73614-204
- Status
- Listed
- Labeler
- Brisk Pharmaceuticals
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216957
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73614-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLINDAMYCIN HYDROCHLORIDE150 mg/1
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73614-204-03 | 73614020403 | 30 CAPSULE in 1 BOTTLE (73614-204-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2de041be-1d36-ee95-e063-6294a90a2091
Use it
Look up 73614-204 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73614-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73614-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.